Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 1445620)

Published in Mol Carcinog on January 01, 1992

Authors

V I Oreffo1, H W Lin, P H Gumerlock, S A Kraegel, H Witschi

Author Affiliations

1: Toxic Substances Research and Teaching Program, University of California, Davis 95616-8615.

Articles by these authors

Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science (2001) 3.37

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18

Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells. Mol Endocrinol (1997) 1.90

Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997) J Am Vet Med Assoc (1998) 1.50

Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice. Lab Invest (1977) 1.46

Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol (1976) 1.45

Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR. J Clin Microbiol (1995) 1.44

Pulmonary fibrosis--a possible mechanism. Toxicol Appl Pharmacol (1979) 1.30

Genotyping of Clostridium difficile isolates. J Infect Dis (1994) 1.29

Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates. J Clin Microbiol (1995) 1.18

Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett (2007) 1.17

Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study. Arch Pathol Lab Med (1998) 1.16

Epithelial-mesenchymal associations of cells in human pulmonary fibrosis and in BHT-oxygen-induced fibrosis in mice. Exp Lung Res (1981) 1.14

Specific detection of Clostridium difficile toxin A gene sequences in clinical isolates. Mol Cell Probes (1994) 1.10

The role of CC10 in pulmonary carcinogenesis: from a marker to tumor suppression. Ann N Y Acad Sci (2000) 1.10

Effects of age on length of hospital stay in a low-income population. Med Care (1975) 1.08

Primary pulmonary responses to toxic agents. CRC Crit Rev Toxicol (1977) 1.07

Patterns of cell proliferation during recovery from oxygen injury. Species differences. Am Rev Respir Dis (1986) 1.05

Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction. Clin Infect Dis (1993) 1.05

MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res (1998) 1.04

Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm (2001) 1.01

p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst (1994) 0.99

A recommended occupational exposure limit for formaldehyde based on irritation. J Toxicol Environ Health (1997) 0.97

Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. Cancer Genet Cytogenet (1985) 0.97

Electron microscopy of butylated hydroxytoluene-induced lung damage in mice. Exp Mol Pathol (1977) 0.96

Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J Natl Cancer Inst (1977) 0.95

Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. Lab Invest (1982) 0.95

Post-ischemic activation of protein kinase C ε protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flow. Neurosci Lett (2010) 0.94

Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol (1997) 0.94

p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst (1993) 0.92

Inhibition of butylated hydroxytoluene-induced mouse lung cell division by oxygen: time-effect and dose-effect relationships. Chem Biol Interact (1977) 0.92

Overexpression of CC10 modifies neoplastic potential in lung cancer cells. Cell Growth Differ (1998) 0.92

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. Cancer (1998) 0.91

Metal phthalocyanine nanoribbons and nanowires. J Phys Chem B (2006) 0.90

Systemic pulmonary toxicity--a puzzler. J Toxicol Clin Toxicol (1996) 0.90

Fecal shedding of Clostridium difficile in dogs: a period prevalence survey in a veterinary medical teaching hospital. J Vet Diagn Invest (1994) 0.90

Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward. Clin Infect Dis (1997) 0.89

In vivo oxidation of reduced nicotinamide-adenine dinucleotide phosphate by paraquat and diquat in rat lung. Chem Biol Interact (1977) 0.89

Proliferative responses of type 2 lung epithelial cells after X rays and fission neutrons. Radiat Res (1980) 0.89

Histochemical characterization of non-neuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am J Pathol (1995) 0.88

Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosomes Cancer (1996) 0.88

Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate (1998) 0.88

Adenosquamous carcinoma arising in a mucinous cystadenoma of the pancreas. J Surg Oncol (1997) 0.87

A comparative study of in vivo RNA and protein synthesis in rat liver and lung. Cancer Res (1972) 0.87

Studies on the pathogenesis of butylated hydroxytolueneinduced lung damage in mice. Toxicol Appl Pharmacol (1978) 0.87

Molecular-clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach. Lung Cancer (2001) 0.87

Intratracheal versus intravenous administration of bleomycin in mice: acute effects. Toxicol Appl Pharmacol (1986) 0.87

Apparent outbreaks of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital. J Vet Diagn Invest (1995) 0.86

Toxicity of butylated hydroxytoluene in mouse following oral administration. Toxicology (1978) 0.86

Effects of hyperoxia on growth characteristics of metastatic murine tumors in the lung. Cancer Res (1988) 0.86

K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Carcinogenesis (1993) 0.86

c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene (1988) 0.86

RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma. Clin Cancer Res (1999) 0.85

Acute inhalation toxicity of 3-methylfuran in the mouse: pathology, cell kinetics, and respiratory rate effects. Toxicol Appl Pharmacol (1984) 0.85

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis (2004) 0.85

Effects of drug metabolism inhibitors on butylated hydroxytoluene-induced pulmonary toxicity in mice. Toxicol Appl Pharmacol (1980) 0.85

Overexpression of cyclin D1 is rare in human prostate carcinoma. Prostate (1999) 0.85

The influence of hyperoxia on the acute toxicity of paraquat and diquat. Drug Chem Toxicol (1979) 0.85

The effect of 3-methylfuran inhalation exposure on the rat nasal cavity. Toxicology (1984) 0.84

Mitochondrial injury of pulmonary alveolar epithelial cells in acute paraquat intoxication. Exp Mol Pathol (1985) 0.84

The differential expression of hepatic genes between prelaying and laying geese. Poult Sci (2007) 0.84

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial. Cancer Chemother Pharmacol (2001) 0.84

Viral Ha-ras mediated mammary tumor progression. Oncogene (1991) 0.83

The expression of pituitary gland genes in laying geese. Poult Sci (2006) 0.83

Qualitative and quantitative aspects of the biosynthesis of ribonucleic acid and of protein in the liver and the lung of the Syrian golden hamster. Biochem J (1973) 0.82

Decreased fetal weights in rats exposed to sidestream cigarette smoke. Fundam Appl Toxicol (1994) 0.82

Some structural and functional consequences of hepatic adenosine triphosphate deficiency induced by intraperitoneal D-fructose administration. Lab Invest (1970) 0.82

Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice. Cancer Lett (1995) 0.82

Ozone, NO, and NO2: oxidant air pollutants and more. Environ Health Perspect (1994) 0.81

Desorption of some toxic heavy metals from human erythrocytes in vitro. Acta Haematol (1965) 0.81

Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA. Cancer Res (1971) 0.81

Immunolocalization of interleukin-6 in salivary gland tumors. Hum Pathol (1995) 0.80

Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer (1991) 0.80

K-ras activation in non-small cell lung cancer in the dog. Cancer Res (1992) 0.80

Concentration-response relationships of rat lungs to exposure to oxidant air pollutants: a critical test of Haber's Law for ozone and nitrogen dioxide. Toxicol Appl Pharmacol (1992) 0.80

Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis. Carcinogenesis (1998) 0.80

Attenuation of pulmonary fibrosis in mice by aminophylline. Biochem Pharmacol (1985) 0.80

Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat. Toxicology (1995) 0.80

Critical Lym-1 binding residues on polymorphic HLA-DR molecules. Mol Immunol (1999) 0.79

Target organ toxicity: lung introduction. Environ Health Perspect (1976) 0.79

Biochemical pathology of lung damage produced by chemicals. Fed Proc (1976) 0.79

Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clin Cancer Res (1997) 0.79

Modification by ozone of lung tumor development in mice. J Natl Cancer Inst (1987) 0.79

Cells of origin of lung tumors in mice. J Natl Cancer Inst (1983) 0.79

Disintegration of lung peroxisomes during differentiation of type II cells to type I cells in butylated hydroxytoluene-administered mice. Exp Mol Pathol (1983) 0.79

Airway epithelial labeling index as an indicator of ozone induced lung injury. Toxicology (1993) 0.79

Analysis of the equine tumor suppressor gene p53 in the normal horse and in eight cutaneous squamous cell carcinomas. Cancer Lett (1996) 0.79

Toxicity of cationic lipid-ribozyme complexes in human prostate tumor cells can mimic ribozyme activity. Biochem Mol Med (1996) 0.79

Conservative conization for microinvasive carcinoma of the cervix. Am J Obstet Gynecol (1997) 0.79

Animal model of human disease. Diffuse interstitial pulmonary fibrosis. Pulmonary fibrosis in mice induced by treatment with butylated hydroxytoluene and oxygen. Am J Pathol (1981) 0.78

Beryllium-induced ultrastructural changes in intact and regenerating liver. Arch Environ Health (1973) 0.78

Molecular biology of prostate cancer. World J Urol (1996) 0.78

Biochemical paramters of BHT-induced cell growth in mouse lung. Chem Biol Interact (1976) 0.78

Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol (1999) 0.78

Enhancement of adenoma formation in mouse lung by butylated hydroxytoluene. Toxicol Appl Pharmacol (1979) 0.78

Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues. Hum Pathol (1996) 0.78

Abundantly expressed hepatic genes and their differential expression in liver of prelaying and laying geese. Poult Sci (2009) 0.78

Cumulative labeling indices in epithelial cell populations of the respiratory tract after exposure to ozone at low concentrations. Toxicol Appl Pharmacol (1995) 0.78

Inhibition of deoxyribonucleic acid synthesis in regenerating rat liver by beryllium. Lab Invest (1968) 0.78